David Ricardo Muñoz Guzmán

business executiveMale0.0Global Dominance: 0.00%

David Ricardo Muñoz Guzmán is the CEO of Pint Pharma, where he focuses on advancing the company’s commitment to community-centered healthcare. His leadership has been pivotal in the launch of BESREMi® in Brazil, offering new hope for patients suffering from Polycythemia Vera.

Power0

Reach0

Collect

Not in the pool (under ¢1).

Recent news mentions

David Ricardo Muñoz Guzmán, CEO of Pint Pharma, emphasized the company's commitment to being community-focused and improving patient access to treatments.

Pint Pharma Anuncia la Aprobación de BESREMi® (ropeginterferón alfa-2b) por parte de ANVISA para el Tratamiento de la Policitemia Vera

El Nacional·

Venezuela· 2025-03-21

9.0

Also mentioned